Document is current
Any future updates will be listed below
-
Authors
Mao, Jun J.
Bryl, Karolina https://orcid.org/0000-0002-1804-367X
Gillespie, Erin F.
Green, Angela
Hung, Tony K. W.
Baser, Raymond https://orcid.org/0000-0002-1644-4090
Panageas, Katherine
Postow, Michael A.
Daly, Bobby
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (P30 CA008748)
JDJ Foundation, AKTIV Against Cancer, Translational and Integrative Medicine Research Fund at Memorial Sloan Kettering Cancer Center
U.S. Department of Health & Human Services | NIH | National Cancer Institute (K08 CA252640)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1P50CA271357-01)
Emerson Collective
- License Information
-
More Information
Article History
Received: 19 July 2024
Accepted: 10 December 2024
First Online: 14 January 2025
Competing interests
: J.J.M.: Research Funding: Tibet Cheezheng Tibetan Medicine Co. Ltd., Zhongke Health International LLC. K.B.: None meeting criteria for this time period. EG: Other Relationship: eContour. A.G.: Consulting or Advisory Role: Merck; Research Funding: Lilly, Mereo BioPharma. KW(T)H: Stock and Other Ownership Interests: TeamX Medical Group; Patents, Royalties, Other Intellectual Property: LookUpTrials (patent pending). R.B.: None meeting criteria for this time period. K.P.: Stock and Other Ownership Interests: 23andMe, Adicet Bio, Chinook Therapeutics, Codexis, T2 Biosystems, Vincerx Pharma; Research Funding: American Association for Cancer Research (AACR). M.A.P.: Consulting or Advisory Role: Bristol-Myers Squibb, Cancer Expert Now, Chugai Pharma, Eisai, Erasca Inc, Intellisphere, Merck, MJH Associates, Nektar, Novartis, Pfizer, WebMD; Research Funding: Array BioPharma, Bristol-Myers Squibb, Infinity Pharmaceuticals, Merck, Novartis, Rgenix. B.D.: Stock and Other Ownership Interests: CVS Health, Lilly, Roche/Genentech; Consulting or Advisory Role: Varian Medical Systems and I-MAB Biopharma.
